Newsfeeds - Spark Newswire

1 minute read

SVB Leerink Downgrades Gemini Therapeutics to Market Perform, Lowers Price Target to $2

Today, 10:07 PM

SVB Leerink analyst Marc Goodman downgrades Gemini Therapeutics (NASDAQ:GMTX) from Outperform to Market Perform and lowers the price target from $10 to $2.

GMTX

1 minute read

Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold

By Vandana Singh

Today, 10:07 PM

Jefferies has cut Gemini Therapeutics Inc (NASDAQ: GMTX) to Hold as the Company explores alternatives.

GMTX

7 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 10:07 PM

During Tuesday's trading, 98 companies set new 52-week lows.

AAON

13 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For March 1, 2022

By Benzinga Insights

Today, 10:07 PM

Upgrades

ACLX

1 minute read

Jefferies Downgrades Gemini Therapeutics to Hold, Lowers Price Target to $1.5

By Benzinga Newsdesk

Today, 10:07 PM

Jefferies analyst Chris Howerton downgrades Gemini Therapeutics (NASDAQ:GMTX) from Buy to Hold and lowers the price target from $23 to $1.5.

GMTX

30 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 10:07 PM

During Tuesday's trading, 505 companies set new 52-week lows.

ACRX

1 minute read

SVB Leerink Maintains Outperform on Gemini Therapeutics, Lowers Price Target to $10

By Benzinga Newsdesk

Today, 10:07 PM

SVB Leerink maintains Gemini Therapeutics (NASDAQ:GMTX) with a Outperform and lowers the price target from $15 to $10.

GMTX

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 10:07 PM

During Friday's session, 445 companies made new 52-week lows.

AAOI

1 minute read

SVB Leerink Maintains Outperform on Gemini Therapeutics, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 10:07 PM

SVB Leerink analyst Marc Goodman maintains Gemini Therapeutics (NASDAQ:GMTX) with a Outperform and lowers the price target from $25 to $15.

GMTX

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:07 PM

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.

ABM